{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:05:41Z","timestamp":1793970341541,"version":"4.8.0"},"reference-count":44,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2021,4,1]]},"DOI":"10.1001\/jamadermatol.2020.5844","type":"journal-article","created":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T16:37:22Z","timestamp":1614789442000},"page":"413","source":"Crossref","is-referenced-by-count":38,"title":["Association of Patient Mental Health Status With the Level of Agreement Between Patient and Physician Ratings of Psoriasis Severity"],"prefix":"10.1001","volume":"157","author":[{"given":"Ewan","family":"Carr","sequence":"first","affiliation":[{"name":"Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satveer K.","family":"Mahil","sequence":"additional","affiliation":[{"name":"St John\u2019s Institute of Dermatology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anamaria","family":"Brailean","sequence":"additional","affiliation":[{"name":"Department of Psychological Medicine, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejus","family":"Dasandi","sequence":"additional","affiliation":[{"name":"St John\u2019s Institute of Dermatology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew E.","family":"Pink","sequence":"additional","affiliation":[{"name":"St John\u2019s Institute of Dermatology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan N.","family":"Barker","sequence":"additional","affiliation":[{"name":"St John\u2019s Institute of Dermatology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Rayner","sequence":"additional","affiliation":[{"name":"Department of Psychological Medicine, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Turner","sequence":"additional","affiliation":[{"name":"St John\u2019s Institute of Dermatology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley","family":"Goldsmith","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine H.","family":"Smith","sequence":"additional","affiliation":[{"name":"St John\u2019s Institute of Dermatology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"doi200084r2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases: epidemiology.","volume":"76","author":"Takeshita","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"doi200084r3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00281-015-0539-8","article-title":"Update on psoriasis immunopathogenesis and targeted immunotherapy.","volume":"38","author":"Mahil","year":"2016","journal-title":"Semin Immunopathol"},{"issue":"5","key":"doi200084r4","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1111\/bjd.v182.5","article-title":"Psoriasis treat to target: defining outcomes in psoriasis using data from a real-world, population-based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR).","volume":"182","author":"Mahil","year":"2020","journal-title":"Br J Dermatol"},{"issue":"4","key":"doi200084r5","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.jaad.2018.11.057","article-title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.","volume":"80","author":"Menter","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"doi200084r7","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/bjd.2017.177.issue-3","article-title":"British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017.","volume":"177","author":"Smith","year":"2017","journal-title":"Br J Dermatol"},{"issue":"9","key":"doi200084r8","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1111\/jdv.2018.32.issue-9","article-title":"Patient-dermatologist agreement in psoriasis severity, symptoms and satisfaction: results from a real-world multinational survey.","volume":"32","author":"Griffiths","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"doi200084r9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3109\/09546634.2013.861891","article-title":"The relationship between pruritus and the clinical signs of psoriasis in patients receiving tofacitinib.","volume":"26","author":"Bushmakin","year":"2015","journal-title":"J Dermatolog Treat"},{"key":"doi200084r10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/2475530319854781","article-title":"Correlation of Physician-Assessed Psoriasis Area and Severity Index scores with patient-reported Psoriasis Symptoms and Signs Diary scores among patients with moderate-to-severe psoriasis: results from VOYAGE 1 and VOYAGE 2 Studies.","volume":"4","author":"Gordon","journal-title":"J Psoriasis Psoriatic Arthritis"},{"issue":"3","key":"doi200084r11","first-page":"675","article-title":"Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity.","volume":"27","author":"Neville","year":"2000","journal-title":"J Rheumatol"},{"issue":"3","key":"doi200084r12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/ajg.2009.685","article-title":"Factors associated with non-adherence to oral medication for inflammatory bowel disease: a systematic review.","volume":"105","author":"Jackson","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"doi200084r13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2105\/AJPH.71.2.127","article-title":"The influence of patient-practitioner agreement on outcome of care.","volume":"71","author":"Starfield","year":"1981","journal-title":"Am J Public Health"},{"issue":"2","key":"doi200084r14","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/acr.v67.2","article-title":"Factors explaining the discrepancy between physician and patient global assessment of joint and skin disease activity in psoriatic arthritis patients.","volume":"67","author":"Eder","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"doi200084r15","first-page":"1293","article-title":"Sources of discrepancy in patient and physician global assessments of rheumatoid arthritis disease activity.","volume":"31","author":"Nicolau","year":"2004","journal-title":"J Rheumatol"},{"issue":"6","key":"doi200084r16","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/acr.20132","article-title":"Patient-physician discordance in assessments of global disease severity in rheumatoid arthritis.","volume":"62","author":"Barton","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"doi200084r17","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/acr.20685","article-title":"Determinants of discordance in patients\u2019 and physicians\u2019 rating of rheumatoid arthritis disease activity.","volume":"64","author":"Khan","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"doi200084r18","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1002\/art.34543","article-title":"Discrepancies between patients and physicians in their perceptions of rheumatoid arthritis disease activity.","volume":"64","author":"Studenic","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"4","key":"doi200084r19","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2340\/00015555-3114","article-title":"Patients with moderate to severe psoriasis associate with higher risk of depression and anxiety symptoms: results of a multivariate study of 300 Spanish individuals with psoriasis.","volume":"99","author":"Trib\u00f3","year":"2019","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"doi200084r20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/13548506.2014.902483","article-title":"A pilot study examining mindfulness-based cognitive therapy in psoriasis.","volume":"20","author":"Fordham","year":"2015","journal-title":"Psychol Health Med"},{"issue":"3","key":"doi200084r21","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.genhosppsych.2013.12.004","article-title":"Embedding integrated mental health assessment and management in general hospital settings: feasibility, acceptability and the prevalence of common mental disorder.","volume":"36","author":"Rayner","year":"2014","journal-title":"Gen Hosp Psychiatry"},{"issue":"4","key":"doi200084r22","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/jid.2009.391","article-title":"How good are clinical severity and outcome measures for psoriasis? quantitative evaluation in a systematic review.","volume":"130","author":"Spuls","year":"2010","journal-title":"J Invest Dermatol"},{"issue":"9","key":"doi200084r23","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1007\/s11136-013-0384-y","article-title":"Psychometric validation of the Physician Global Assessment scale for assessing severity of psoriasis disease activity.","volume":"22","author":"Cappelleri","year":"2013","journal-title":"Qual Life Res"},{"issue":"11","key":"doi200084r24","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1097\/01.MLR.0000093487.78664.3C","article-title":"The Patient Health Questionnaire-2: validity of a two-item depression screener.","volume":"41","author":"Kroenke","year":"2003","journal-title":"Med Care"},{"issue":"9","key":"doi200084r25","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure.","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"issue":"10","key":"doi200084r26","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7.","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"key":"doi200084r27","first-page":"65","article-title":"Psoriasis and smoking: links and risks.","volume":"6","author":"Naldi","year":"2016","journal-title":"Psoriasis (Auckl)"},{"issue":"5","key":"doi200084r28","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1111\/bjd.v181.5","article-title":"Does weight loss reduce the severity and incidence of psoriasis or psoriatic arthritis? a critically appraised topic.","volume":"181","author":"Mahil","year":"2019","journal-title":"Br J Dermatol"},{"issue":"4","key":"doi200084r29","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/bjd.v183.4","article-title":"British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update.","volume":"183","author":"Smith","year":"2020","journal-title":"Br J Dermatol"},{"issue":"5","key":"doi200084r30","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/bjd.2019.180.issue-5","article-title":"Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study.","volume":"180","author":"Warren","year":"2019","journal-title":"Br J Dermatol"},{"issue":"11","key":"doi200084r31","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1038\/jid.2015.208","article-title":"Differential drug survival of biologic therapies for the treatment of psoriasis: a prospective observational cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).","volume":"135","author":"Warren","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"4","key":"doi200084r32","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1037\/h0026256","article-title":"Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit.","volume":"70","author":"Cohen","year":"1968","journal-title":"Psychol Bull"},{"key":"doi200084r33","first-page":"19","article-title":"Regression standard errors in clustered samples.","volume":"13","author":"Rogers","journal-title":"Stata Technical Bulletin"},{"issue":"8","key":"doi200084r35","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1111\/imj.12212","article-title":"Alignment: a conceptual shift from adherence.","volume":"43","author":"Selzer","year":"2013","journal-title":"Intern Med J"},{"issue":"6","key":"doi200084r36","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1111\/bjd.2013.168.issue-6","article-title":"Is the prevalence of psoriasis increasing? a 30-year follow-up of a population-based cohort.","volume":"168","author":"Danielsen","year":"2013","journal-title":"Br J Dermatol"},{"issue":"5","key":"doi200084r37","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jpsychores.2007.11.010","article-title":"Risk factors of symptom underestimation by physicians.","volume":"64","author":"Zastrow","year":"2008","journal-title":"J Psychosom Res"},{"key":"doi200084r38","doi-asserted-by":"publisher","first-page":"l1476","DOI":"10.1136\/bmj.l1476","article-title":"Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis.","volume":"365","author":"Levis","year":"2019","journal-title":"BMJ"},{"issue":"1","key":"doi200084r39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000502294","article-title":"The accuracy of the Patient Health Questionnaire-9 algorithm for screening to detect major depression: an individual participant data meta-analysis.","volume":"89","author":"He","year":"2020","journal-title":"Psychother Psychosom"},{"issue":"2","key":"doi200084r40","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1192\/bjpo.bp.115.001685","article-title":"Case finding and screening clinical utility of the Patient Health Questionnaire (PHQ-9 and PHQ-2) for depression in primary care: a diagnostic meta-analysis of 40 studies.","volume":"2","author":"Mitchell","year":"2016","journal-title":"BJPsych Open"},{"issue":"2","key":"doi200084r41","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/bjd.2015.173.issue-2","article-title":"Demographics and disease characteristics of patients with psoriasis enrolled in the British Association of Dermatologists Biologic Interventions Register.","volume":"173","author":"Iskandar","year":"2015","journal-title":"Br J Dermatol"},{"issue":"8","key":"doi200084r42","first-page":"891","article-title":"The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study.","volume":"146","author":"Kurd","year":"2010","journal-title":"Arch Dermatol"},{"issue":"1","key":"doi200084r43","first-page":"48","article-title":"German psoriasis registry PsoBest: objectives, methodology and baseline data.","volume":"12","author":"Augustin","year":"2014","journal-title":"J Dtsch Dermatol Ges"},{"issue":"1","key":"doi200084r44","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/bjd.2014.171.issue-1","article-title":"Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR).","volume":"171","author":"Kimball","year":"2014","journal-title":"Br J Dermatol"},{"key":"doi200084r1","volume-title":"Global report on psoriasis","author":"Michalek","year":"2016"},{"key":"doi200084r34","author":"Stata Statistical Software","year":"2017"},{"key":"doi200084r6","unstructured":"NICE. Psoriasis: assessment and management. Updated September 1, 2017. Accessed July 2, 2020. https:\/\/www.nice.org.uk\/guidance\/cg153\/chapter\/Introduction#systemic-therapy"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2777011\/jamadermatology_carr_2021_oi_200084_1618863510.56123.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T12:28:16Z","timestamp":1619094496000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2777011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2020.5844","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,1]]}}}